The Zacks Analyst Blog Highlights: Toyota Motor, Honda Motor, General Motors, Ford Motor, Nissan Motor, Daimler and Hyundai Motor

Nov 03, 2011, 09:30 ET from Zacks Investment Research, Inc.

CHICAGO, Nov. 3, 2011 /PRNewswire/ -- announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Toyota Motor Corp. (NYSE: TM), Honda Motor Corp. (NYSE: HMC), General Motors Co. (NYSE: GM), Ford Motor Co. (NYSE: F), Nissan Motor Co. (OTC: NSANY), Daimler (OTC: DDAIF) and Hyundai Motor (OTC: HYMLF).


Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter:

Here are highlights from Wednesday's Analyst Blog:

U.S. Auto Market: Best October in 4 Years

Light vehicle sales in the U.S. rose 7.5% to 1.02 million units during October, the best since October 2007, driven by strong sales of sports utility vehicles (SUVs) and trucks. At seasonally adjusted annualized rate, sales increased 8% to 13.3 million units from 12.3 million units in October 2010.

Total car sales escalated 7.4% to 468,533 units while sales of light trucks (minivans, sport utility vehicles and pick up trucks) went up 7.6% to 548,799 units (all including imports).

All the major automakers posted a rise in sales during the month, except Toyota Motor Corp. (NYSE: TM) and Honda Motor Corp. (NYSE: HMC) due to parts supply shortages following the earthquake and tsunami on March 11, 2011.

U.S. Automakers

Sales at General Motors Co. (NYSE: GM) edged up 1.9% to 186,895 vehicles. The marginal rise in sales was attributable to increase in sales of Chevrolet brands of vehicles (6%) and decrease in sales of other brands (GMC, Buick and Cadillac). The automaker saw strong demand for SUV Chevrolet Equinox, and cars including Camaro and Cruze. Its plug-in Chevrolet Volt recorded its best month with the sale of 1,100 units.

Sales at Ford Motor Co. (NYSE: F) rose 6% to 167,803 cars and trucks, with strong demand for SUVs including Explorer and Escape. Sales of Ford branded vehicles rose 12.6% while that of Lincoln fell 10.8% during the month.

Sales at Chrysler Group LLC soared 27% to 114,512 vehicles, driven by Jeep brand and Ram trucks. The company's namesake brand posted its best October since 2007. The Jeep brand sales were helped by the new compact SUV Compass as well as the Wrangler.

Japanese Automakers

Sales at Toyota dipped 7.9% to 134,046 vehicles. Sales of Toyota's best-selling vehicle Camry fell 11.9% to 22,043 vehicles while sales of Corolla declined 12.8% to 16,244 vehicles.

Sales at Honda dipped marginally to 98,333 vehicles from 98,811 vehicles in October 2010. Its best-selling model was Accord, which saw a 5.3% rise in sales to 22,589 units.

Sales at Nissan Motor Co. (OTC: NSANY) appreciated 18% to 82,346 vehicles during the month under study. Nissan Division sales grew 22.1% while Infiniti vehicles sales slid 13.5%. The company's best-selling models during the month included Versa sedan, Nissan Altima, and Rogue crossover.

Other Automakers

Sales at Daimler's (OTC: DDAIF) Mercedes-Benz grew 28% to 24,449 vehicles, driven by the C-Class model (88% increase), CLS-Class (more than doubled) and, SLK Roadster (58.2% increase).

Sales at Hyundai Motor (OTC: HYMLF) went up 23% to 52,402 vehicles. Elantra, Santa Fe, and Tucson are some of the models which showed significant sales growth during the month. Meanwhile, sales at Kia Motors increased 21% to 37,690 units, with strong demand for Optima, Soul and Sportage models.

Our Take

We are overwhelmed by the impressive growth in auto sales in the U.S. Since the global economic crisis kicked in, we have seen such sales growth when the government announced the Cash for Clunkers program in August 2009.

According to, industry's average transaction price was $30,487 during the month under study, up $138 from September this year and up $1,390 from October 2010. This clearly indicates an upward trend in vehicle sales.

However, we are still worried about the higher unemployment rate (9%), surging food and clothing costs and a weak consumer confidence.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter:

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today:

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at

Visit for information about the performance numbers displayed in this press release.

Follow us on Twitter:

Join us on Facebook:

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339

SOURCE Zacks Investment Research, Inc.